Research & evidence reviews
Articles
Research notes, evidence reviews, regulatory updates, and editorial deep dives. Browse 140 published pieces with the same evidence-first, safety-aware approach used across the profile library.
Exercise for Insomnia: What the 2024–2025 Evidence Actually Shows
Evidence-first review of exercise for insomnia, including subjective vs objective sleep outcomes, exercise types, timing, CBT-I context, and recent meta-analyses.
Read articleInsomnia Evidence Guide: Why You Cannot Sleep, What to Check, and What Actually Helps
Evidence-first guide to insomnia: sleep-onset vs maintenance problems, CBT-I, circadian timing, sleep apnea, restless legs, medications, substances, sleep hygiene, and where supplements fit.
Read articleWhy Am I Still Tired After 8 Hours of Sleep? A Guide to Non-Restorative Sleep
An evidence-first guide to non-restorative sleep: why enough time in bed can still leave you unrefreshed, how sleep quality differs from duration, and when apnea, insomnia, circadian mismatch, restless legs, medications, pain, mood, or hypersomnolence deserve attention.
Read articleSleep Hygiene vs CBT-I: Why Basic Sleep Tips Are Not the Same as Insomnia Treatment
Evidence-first comparison of sleep hygiene and cognitive behavioral therapy for insomnia, including the 2025 sleep-hygiene meta-analysis, CBT-I components, and what each approach can and cannot do.
Read articleSleep Interventions Evidence Matrix: Supplements, Habits, Circadian Tools, and Red Flags
A decision-first evidence matrix comparing sleep science, supplements, CBT-I, circadian tools, environment, substances, life stages, and sleep-disorder red flags by strongest human outcome and biggest limitation.
Read articleWhy Do I Wake Up at 3 AM? An Evidence-First Guide to Middle-of-the-Night Awakenings
Evidence-first guide to waking at 3 AM, sleep-maintenance insomnia, alcohol, sleep apnea, circadian timing, stress, medications, and when repeated awakenings deserve evaluation.
Read article5-HTP for Sleep: Limited Evidence, Serotonin Pathways & Safety
A cautious review of 5-HTP for sleep, including the 2024 randomized trial in older adults, limits of the insomnia evidence, and serotonergic interaction concerns.
Read articleThe 90-Minute Sleep Cycle Myth: Sleep Cycles Are Real, but They Are Not a Timer
Evidence review of the 90-minute sleep-cycle claim, including 6,064 polysomnographic cycles, large individual variability, shorter first cycles, sleep pressure, age, sex, REM changes, and why exact 90-minute alarm math is not evidence-based.
Read articleAdvanced Sleep-Wake Phase Disorder: Early Bedtimes, Early Waking and When It Is More Than Just Being a Morning Person
Evidence review of advanced sleep-wake phase disorder, including early circadian timing, aging, familial forms, diagnosis, evening light therapy, melatonin uncertainty, and the difference between a shifted body clock and insomnia.
Read articleAlcohol and Sleep: Why Falling Asleep Faster Can Mean Worse Sleep
A research review of alcohol before bed, REM sleep, sleep onset, dose-response effects, sleep architecture, and why sedation is not the same as restorative sleep.
Read articleAnxiety and Sleep: Insomnia, Hyperarousal, CBT-I and the Bidirectional Evidence
Evidence review of anxiety and sleep, including insomnia, hyperarousal, GAD, panic, PTSD, OCD, CBT-I, sleep-related worry, and why treating insomnia can help anxiety without replacing anxiety-specific care.
Read articleAshwagandha Benefits, Sleep & Stress Evidence: What the Science Actually Shows
Evidence-based 2026 review of ashwagandha for stress, anxiety and sleep, including meta-analyses, formulation limits, study-dose context, thyroid concerns, rare liver injury and medication safety.
Read articleBedroom Air Quality and Sleep: Ventilation, CO₂, Pollution, and What the Evidence Actually Shows
Evidence review of bedroom ventilation and sleep, including controlled field studies of CO2 and airflow, air-pollution meta-analysis, tracker limitations, and why one universal bedroom CO2 threshold is not established.
Read articleBlue Light, Screens and Sleep: What Actually Matters
Blue light affects circadian biology, but bedtime screen advice is often oversimplified. Review the evidence on blue-blocking glasses, device light, timing, and sleep outcomes.
Read articleCaffeine and Sleep: How Late Is Too Late? Evidence on Timing and Dose
What controlled trials and meta-analyses show about caffeine timing, total sleep time, sleep latency, deep sleep, dose, and why a universal afternoon cutoff is too simple.
Read articleCannabis and Sleep: What the 2025–2026 Evidence Actually Shows
Evidence review of cannabis, THC, CBD, CBN and sleep, including 2025–2026 meta-analyses, insomnia trials, sleep architecture, recreational-use data, and formulation-specific limits.
Read articleCBT-I vs Sleep Supplements: What the Evidence Actually Supports
Chronic insomnia is not just a supplement problem. Compare CBT-I with sleep supplements using AASM and ACP guidelines, including what changes when medication is added.
Read articleChamomile for Sleep: What the Trials and Meta-Analyses Say
Evidence review of chamomile for sleep quality and insomnia, including the 2024 meta-analysis, chronic-insomnia trial, outcome-specific benefits, and safety limits.
Read articleChronic Pain and Sleep: Why Poor Sleep Can Make Pain Worse
Evidence review of the bidirectional relationship between chronic pain and sleep, including longitudinal data, sleep deprivation, CBT-I, daily pain-sleep patterns and why better sleep does not automatically erase pain.
Read articleCPAP vs Oral Appliance for Sleep Apnea: Which Works Better?
Evidence comparison of CPAP and mandibular advancement oral appliances for obstructive sleep apnea, separating AHI and oxygenation efficacy from adherence, symptoms, dental tradeoffs, and patient fit.
Read articleDaytime Sleepiness vs Fatigue: They Feel Similar but Point to Different Problems
Evidence-based guide to excessive daytime sleepiness versus fatigue, including unintentional sleep episodes, microsleeps, sleep deprivation, sleep apnea, hypersomnolence disorders, and why 'tired' is too vague for diagnosis.
Read articleDelayed Sleep-Wake Phase vs Insomnia: When the Clock Is the Problem
Evidence review of delayed sleep-wake phase disorder versus insomnia, including later-normal sleep, sleep diaries, actigraphy, morning light, melatonin timing, and why bedtime sedation can miss the mechanism.
Read articleDepression and Sleep: Insomnia, Hypersomnia, CBT-I and the Bidirectional Evidence
Evidence review of depression and sleep, including insomnia, hypersomnia, CBT-I, depressive symptoms, prevention evidence, circadian disruption, and why treating insomnia can improve depression without replacing depression-specific care.
Read articleExercise Timing and Sleep: Is Working Out at Night Actually Bad?
A 2026 evidence review of morning vs evening exercise, sleep continuity, intensity, proximity to bedtime, and why the old 'never exercise at night' rule is too simple.
Read articleExploding Head Syndrome: The Painless Sleep-Transition 'Bang' and What the Evidence Says
Evidence review of exploding head syndrome, including sleep-transition timing, prevalence uncertainty, flashes of light, fear, differential diagnosis, benign prognosis, reassurance and the limits of treatment evidence.
Read articleEye Masks, Earplugs, and Sleep: Strongest in Noisy Clinical Environments
Evidence review of eye masks and earplugs for sleep, including the 2026 ICU systematic review, prior meta-analyses, subjective-vs-objective findings, and why hospital evidence does not automatically generalize to quiet bedrooms.
Read articleHome Sleep Apnea Test vs Polysomnography: What Each Test Can Miss
Evidence-based comparison of home sleep apnea testing and in-lab polysomnography for obstructive sleep apnea, including recording-time bias, REM and arousal limitations, night-to-night variability, and when a negative home test needs follow-up.
Read articleHops for Sleep: Most Human Evidence Is Really Valerian + Hops Evidence
Evidence review of Humulus lupulus for sleep, including valerian-hops randomized trials, the 2025 feasibility RCT, objective-vs-subjective outcomes, and why combination evidence cannot prove a standalone hops effect.
Read articleHow Much Sleep Do Adults Need? Why 7+ Hours Is Not an Exact Eight-Hour Rule
Evidence-first guide to adult sleep duration: the AASM/SRS 7-or-more-hours consensus, individual variation, recovery sleep, long-sleep associations, and why one exact nightly target does not fit everyone.
Read articleHypersomnolence vs Insufficient Sleep: When Daytime Sleepiness Needs a Deeper Workup
Evidence-based guide to persistent excessive daytime sleepiness, insufficient sleep, narcolepsy, idiopathic hypersomnia, polysomnography, MSLT limitations, actigraphy, and why adequate sleep opportunity must be established before labeling a central hypersomnolence disorder.
Read articleIdiopathic Hypersomnia vs Narcolepsy: Sleep Inertia, Long Sleep, MSLT and the Diagnostic Gray Zone
Evidence review comparing idiopathic hypersomnia with narcolepsy type 1 and type 2, including sleep inertia, long sleep duration, cataplexy, SOREMPs, MSLT limitations, diagnostic overlap, and current AASM treatment guidance.
Read articleInsomnia vs Sleep Deprivation: Same Tired Feeling, Different Problem
A research-based explanation of insomnia disorder, insufficient sleep, sleep opportunity, daytime impairment, and why the distinction changes what evidence is relevant.
Read articleJet Lag: Light, Melatonin, Sleep Timing, and Why Direction Matters
Evidence review of jet lag disorder, including the 2025 CDC Yellow Book, east-versus-west adaptation, timed light and darkness, melatonin evidence, short trips, travel fatigue, and why generic bedtime advice can mis-time the circadian clock.
Read articleL-Tryptophan for Sleep: What the Evidence Actually Shows
A careful review of L-tryptophan for sleep, including the 2022 meta-analysis, sleep-onset versus sleep-maintenance outcomes, guideline context, and serotonergic safety limits.
Read articleLavender for Sleep: What the 2026 Meta-Analysis Actually Shows
Evidence review of lavender essential oil for sleep, including the 2026 meta-analysis, earlier systematic reviews, randomized trials, measurement limits, and formulation differences.
Read articleLemon Balm for Sleep: Promising Extract Data, but Not One Proven Herb Effect
Evidence review of Melissa officinalis for sleep and insomnia, including newer placebo-controlled extract trials, combination studies, formulation limits, and safety context.
Read articleMedications and Sleep: Why Sedating, Activating and Sleep-Architecture Effects Are Not the Same Thing
Evidence review of how prescription medications can affect insomnia, sleepiness, REM sleep, sleep continuity and next-day alertness, with focused sections on antidepressants, stimulants, glucocorticoids and sedating medicines.
Read articleMelatonin Timing vs Dose: Why Clock Time May Matter More Than More Milligrams
Evidence review of melatonin timing and dose, including the 2024 dose-response meta-analysis and 2026 scoping review of 57 systematic reviews and 227 meta-analyses.
Read articleMenopause and Sleep: Hot Flashes, Insomnia, Sleep Apnea and What Actually Helps
Evidence review of sleep problems during perimenopause and menopause, including CBT-I, vasomotor symptoms, hormone therapy, sleep apnea, exercise and why not every awakening is hormonal.
Read articleMigraine and Sleep: Insomnia, Sleep Quality, CBT-I and the Bidirectional Evidence
Evidence review of migraine and sleep, including insomnia, subjective vs objective sleep, CBT-I, migraine prevention, sleep apnea, morning headache, and why poor sleep is both a trigger and a comorbidity rather than one simple cause.
Read articleMindfulness for Insomnia: Better Than Waitlist Is Not the Same as Better Than CBT-I
Evidence review of mindfulness-based interventions for insomnia and sleep disturbance, including positive older meta-analyses, active-control results, MBSR limits, and CBT-I comparisons.
Read articleMorning Light and Sleep Timing: Why Light Works Differently by Clock Time
A research-first guide to morning light, evening light, circadian phase shifts, insomnia, delayed sleep timing, and what recent light-therapy meta-analyses actually show.
Read articleMouth Taping for Sleep: What the Evidence and Safety Reviews Actually Show
Evidence review of mouth taping for sleep, snoring and sleep apnea, including the 2025 systematic review, social-media claims, CPAP-specific research and safety limits.
Read articleMusic for Sleep: Better Subjective Sleep, Much Weaker Objective Evidence
Evidence review of listening to music for insomnia and sleep, including the 2022 Cochrane review, subjective PSQI improvement, weak objective results, and population differences.
Read articleNaps and Nighttime Sleep: When Napping Helps—and When It Can Backfire
A research guide to nap duration, timing, nighttime sleep pressure, cognitive benefits, shift-work contexts, and why 'never nap' is too simple.
Read articleNarcolepsy: Excessive Daytime Sleepiness, Cataplexy, MSLT and What Actually Separates It From Being Tired
Evidence review of narcolepsy type 1 and type 2, including excessive daytime sleepiness, cataplexy, sleep paralysis, REM hallucinations, overnight polysomnography, MSLT, orexin deficiency, diagnostic confounders, and AASM treatment guidance.
Read articleNasal Obstruction, Snoring and Sleep Apnea: What Nasal Strips, Dilators and Nasal Surgery Can—and Cannot—Fix
Evidence review of nasal congestion and obstruction in sleep-disordered breathing, including nasal strips and dilators, snoring, obstructive sleep apnea, nasal surgery, rhinitis, and CPAP tolerance.
Read articleNicotine, Vaping and Sleep: What the Evidence Shows
Evidence review of nicotine, cigarettes, vaping and sleep, including the 2025 e-cigarette meta-analysis, smoking-cessation sleep review, withdrawal effects, and causal limits.
Read articleNight Owl or Delayed Sleep-Wake Phase Disorder? How to Tell the Difference
Evidence review of evening chronotype, delayed sleep-wake phase disorder, insomnia overlap, melatonin timing, morning light and why a late body clock is not automatically a sleep disorder.
Read articleNight Terrors vs Nightmares: NREM Arousal, Dream Recall and How to Tell Them Apart
Evidence review of night terrors versus nightmares, including NREM vs REM timing, recall, autonomic arousal, child vs adult presentation, behavioral management, scheduled awakenings, nightmare treatment and red flags for further evaluation.
Read articleNocturia and Sleep: Why Waking to Urinate Is Not Just a Bladder Problem
Evidence review of nocturia and sleep, including insomnia, nocturnal polyuria, bladder capacity, sleep apnea, bladder diaries, falls, CPAP, and why treatment depends on the underlying mechanism.
Read articleOmega-3 and Sleep: Why the Meta-Analyses Do Not Tell One Simple Story
Evidence review of omega-3 fatty acids and sleep, including the 2024 randomized-trial meta-analysis, the earlier adult-null synthesis, population differences, and endpoint-specific effects.
Read articleOral GABA for Sleep: Human Evidence Is Still Very Limited
Evidence review of oral GABA supplements for sleep, including the 2020 systematic review, small randomized trials, combination-product confounding, and why mechanism claims outrun the data.
Read articleDiphenhydramine and Doxylamine for Sleep: What OTC 'PM' Products Actually Do
Evidence review of diphenhydramine and doxylamine for sleep, including chronic-insomnia guidance, newer trial syntheses, rapid tolerance, next-day effects and anticholinergic safety.
Read articlePassionflower for Sleep: Human Trials, Insomnia Evidence, and Limits
Evidence review of Passiflora incarnata for sleep, including the polysomnography insomnia trial, tea study, 2024 standardized-extract RCT, and 2025 OTC insomnia review.
Read articlePregnancy and Postpartum Sleep: Insomnia, Sleep Apnea, Restless Legs and What Actually Helps
Evidence review of sleep during pregnancy and the first postpartum year, including CBT-I, non-drug interventions, infant-related fragmentation, sleep apnea, restless legs and postpartum mental-health context.
Read articlePTSD, Nightmares and Sleep: CBT-I, Imagery Rehearsal and What the Evidence Actually Shows
Evidence review of PTSD-related insomnia and nightmares, including CBT-I, imagery rehearsal therapy, trauma-focused psychotherapy, prazosin evidence, sleep apnea, and why treating sleep symptoms is not the same as treating all PTSD symptoms.
Read articleREM Sleep Behavior Disorder: Dream Enactment, Safety, Melatonin and the Neurologic Link
Evidence review of REM sleep behavior disorder, including dream enactment, REM sleep without atonia, polysomnography, injury prevention, AASM treatment guidance, melatonin and clonazepam, medication-induced RBD, and the association with Parkinson disease and other synucleinopathies.
Read articleRestless Legs, Iron and Sleep: Why Ferritin Changes the Question
Restless legs syndrome can masquerade as insomnia. Learn why AASM guidance emphasizes iron studies and why blind iron supplementation is not the same as evidence-based RLS care.
Read articleSaffron for Sleep: Evidence, Insomnia Trials, and Limits
Evidence review of saffron for sleep quality and insomnia, including randomized trials, meta-analysis findings, newer 2025 data, dosing context, and uncertainty.
Read articleShift Work Sleep Disorder: What the New AASM Guidance Actually Recommends
Evidence review of shift work sleep disorder, including the 2025-2026 AASM guidance on naps, bright light, caffeine, melatonin, meal timing, rotating schedules and daytime sleep.
Read articleSleep Apnea in Women: Why OSA Can Be Missed
Evidence review of obstructive sleep apnea in women, including symptom patterns, REM-predominant disease, menopause, screening limitations, home sleep testing, and why objective diagnosis still matters.
Read articleSleep Apnea vs Insomnia: Why the Difference Matters
Insomnia and obstructive sleep apnea can overlap. Learn how COMISA changes the evidence picture and why sedating supplements do not address airway obstruction.
Read articleSleep Bruxism and Sleep Apnea: What Teeth Grinding Does—and Does Not—Tell You
Evidence review of sleep bruxism, sleep quality, polysomnographic assessment, and its debated relationship with obstructive sleep apnea, including conflicting meta-analyses and a 2026 umbrella review.
Read articleSleep Bruxism: Teeth Grinding, Jaw Pain, Mouthguards, Sleep Apnea and What the Evidence Actually Shows
Evidence review of sleep bruxism, including modern consensus definitions, diagnosis, jaw pain, tooth wear, occlusal splints, botulinum toxin, sleep quality, sleep apnea overlap, caffeine/alcohol/tobacco associations, and why grinding is not automatically a sleep disorder.
Read articleSleep Debt and Recovery: Why One Good Night Does Not Reset Every Outcome
Evidence review of sleep debt and recovery sleep, including acute versus chronic restriction, cognitive recovery, mood, sleepiness, weekend catch-up sleep, and why different functions recover at different rates.
Read articleSleep Environment Evidence Guide: Light, Noise, Temperature, Air, and Position
Decision-first guide to the sleep environment: darkness, noise control, bedroom temperature, ventilation and CO2, sleep position, and when environmental optimization is more useful than another supplement.
Read articleSleep in Older Adults: Aging, Insomnia, CBT-I, Apnea and Medication Risk
Evidence review of sleep in older adults, including normal age-related sleep changes, insomnia, CBT-I, obstructive sleep apnea, medication risk, naps, and why lighter sleep is not the same as untreatable insomnia.
Read articleSleep Inertia: Why You Feel Groggy After Waking and What Actually Helps
Evidence review of sleep inertia, including nap length, deep sleep, prior sleep loss, caffeine, bright light, safety-critical work and why the 20-minute-nap rule is not universal.
Read articleSleep Onset vs Sleep Maintenance: Why the Difference Changes the Evidence
A research-first guide to sleep-onset latency, wake after sleep onset, total sleep time, sleep efficiency, and why a sleep aid can help one insomnia pattern but not another.
Read articleSleep Paralysis: REM Atonia, Hallucinations, Narcolepsy and What Actually Helps
Evidence review of sleep paralysis, including REM atonia, prevalence uncertainty, hallucinations, sleep deprivation, irregular schedules, narcolepsy differential diagnosis, and why most isolated episodes do not need medication.
Read articleBest Sleep Position? Why the Answer Depends on Sleep Apnea, Reflux, and the Actual Problem
Evidence review of sleep position, including positional therapy for obstructive sleep apnea, left-side sleeping for nocturnal GERD, and why no single side is proven best for overall sleep quality.
Read articleSleep Regularity: Why Consistent Timing May Matter Beyond Sleep Duration
A research review of sleep regularity, health associations, the Sleep Regularity Index, and why consistent sleep timing is emerging as a separate sleep-health dimension.
Read articleSleep-Related Eating Disorder: Parasomnia, Amnesia, Zolpidem and How It Differs From Night Eating
Evidence review of sleep-related eating disorder, including partial arousal, amnesia, safety risks, night eating syndrome differential diagnosis, zolpidem and medication triggers, comorbid sleep disorders, polysomnography, and treatment evidence.
Read articleWhy Sleep Supplement Formulations Are Not Interchangeable
Why evidence for one magnesium salt, saffron extract, tart-cherry product, chamomile preparation, or valerian extract cannot automatically be transferred to every product with the same ingredient name.
Read articleSleep Temperature and Cooling: What Heat, Bedding, and Cooling Studies Show
Evidence review of bedroom heat, body cooling, cooling bedding, and sleepwear, including recent systematic reviews and why cooler is not automatically better.
Read articleHow Accurate Are Sleep Trackers? What 2025–2026 Reviews Say
Evidence review of consumer sleep trackers, actigraphy, polysomnography, sleep-stage estimates, and why wearable sleep scores should complement—not replace—validated sleep assessment.
Read articleSleepwalking and NREM Parasomnias: Triggers, Safety, Diagnosis and What Actually Helps
Evidence review of sleepwalking and NREM disorders of arousal, including sleep deprivation, triggers, injury risk, diagnosis, video-polysomnography, behavioral treatment evidence, hypnosis, and why medication claims are weaker than they often sound.
Read articleSnoring vs Sleep Apnea: When Noise Is a Symptom—and When It Is a Disorder
Evidence-first guide to primary snoring versus obstructive sleep apnea, including red flags, PSG and home sleep apnea testing, negative-test limits, wearables, positional therapy, mouth taping, and why snoring volume alone cannot diagnose OSA.
Read articleSubjective vs Objective Sleep: Why Your Sleep Can Feel Worse Than the Numbers
A research guide to sleep diaries, questionnaires, actigraphy, polysomnography, sleep-state misperception, and why subjective and objective sleep measures often disagree.
Read articleTart Cherry for Sleep: What Human Trials Actually Show
Evidence review of Montmorency tart cherry juice and powder for sleep, including the 2025 systematic review, positive insomnia pilots, null trials, melatonin findings, and practical limits.
Read articleTeen and Adolescent Sleep: Circadian Delay, School Start Times, Insomnia and CBT-I
Evidence review of adolescent sleep, including puberty-related circadian delay, early school schedules, insomnia, CBT-I, delayed sleep-wake phase disorder, light, melatonin, and the difference between insufficient sleep and a sleep disorder.
Read articleTeen Sleep and School Start Times: What Later Starts Actually Change
Evidence review of adolescent sleep and school start times, including the 2026 meta-analysis, randomized school-delay evidence, chronotype, social jet lag, mood outcomes, and why later starts are not a cure for every teen sleep problem.
Read articleTime-Restricted Eating and Sleep: Why the Evidence Looks Contradictory
Evidence review of time-restricted eating, fasting windows, meal timing, and sleep, including recent meta-analyses and randomized-trial reviews.
Read articleTinnitus and Sleep: Insomnia, CBT-I, Sound and the Evidence
Evidence review of tinnitus and sleep, including tinnitus-related insomnia, CBT-I, tinnitus-directed CBT, sleep quality, sound enrichment, mental-health overlap, and why tinnitus loudness is not the same thing as insomnia severity.
Read articleVitamin D and Sleep: A Sleep-Quality Signal, Not a Universal Insomnia Treatment
Evidence review of vitamin D supplementation and sleep, including 2022 meta-analyses, deficiency context, PSQI outcomes, uncertain effects on sleep quantity and disorders, and supplement safety.
Read articleWarm Bath or Shower Before Bed: The Sleep-Onset Evidence and Its Limits
Evidence review of passive body heating before bed, including the 2019 meta-analysis, timing and sleep-onset findings, thermoregulation, and the weaker 2025 hot-foot-bath evidence.
Read articleWeekend Catch-Up Sleep: Can You Repay Sleep Debt?
Weekend catch-up sleep may provide partial short-term recovery, but it does not fully erase chronic sleep debt. Review the 2025 evidence on mood, circadian disruption, and health associations.
Read articleWeighted Blankets for Sleep: Promising Adult Data, Unstable Pooled Evidence
Evidence review of weighted blankets for insomnia and sleep, including 2024 meta-analyses, the 102-person pilot RCT, subjective-vs-actigraphy results, and population limits.
Read articleWhite Noise and Sleep: Newer Meta-Analysis, Pink Noise, and the Limits of Sound Masking
Evidence review of white and pink noise for sleep, comparing the older very-low-certainty literature, the 2025 white-noise RCT meta-analysis, and 2026 polysomnography showing pink noise can reduce REM sleep.
Read articleWhy Sleep Studies Disagree: 9 Reasons the Evidence Looks Messy
Why sleep trials can reach different conclusions: different insomnia phenotypes, endpoints, measurement tools, formulations, doses, sample sizes, placebo response, analysis choices, and study duration.
Read articleBlue Lotus and Sleep: Chemistry, Product Risk, and Evidence Limits
Blue lotus is marketed for sedation, dreams, and relaxation, but human efficacy data are thin and modern vaping products create a major adulteration problem.
Read articleKava Safety: Liver Risk, Product Differences, and What Evidence Supports
Kava has human anxiety research but also rare serious liver-injury reports. This evidence-first review separates traditional use, extract differences, interactions, and claims that go beyond the data.
Read articleMugwort and Dreams: Tradition, Evidence, and Safety Limits
Mugwort has a long reputation as a dream herb, but direct human evidence for vivid or lucid dreams is missing. Here is what tradition, pharmacology, and safety data actually support.
Read articleRhodiola vs Ashwagandha: Evidence, Sleep, Stress, and the Limits of “Adaptogen Matching”
Rhodiola and ashwagandha are often assigned opposite “energizing” and “calming” personalities. Human evidence supports a more careful comparison: ashwagandha has direct sleep meta-analyses, while rhodiola research is centered more on fatigue, stress, and performance.
Read articleBerberine: Blood Sugar, Lipids & Weight — Evidence Review
Evidence review of berberine for glucose, lipids, and weight, with clear limits on the metformin comparison, trial-dose context, drug interactions, and long-term uncertainty.
Read articleNAC (N-Acetyl Cysteine): Respiratory, Glutathione & Mental Health Evidence
Evidence review of NAC for glutathione replenishment, chronic respiratory disease, and psychiatric research, with clear separation between medical use, supplement trials, and safety uncertainty.
Read article7-Hydroxymitragynine (7-OH): Pharmacology, Dependence, Product Testing & Legal Status (2026)
Evidence-first August 2026 review of 7-hydroxymitragynine covering human opioid-receptor pharmacology, respiratory toxicology, dependence and withdrawal evidence, commercial product chemistry, ACMT/FDA guidance, DEA temporary-scheduling notices, and selected current state laws.
Read articleCreatine for Brain Health: Cognition, Sleep Loss, Mood & Safety — 2026 Review
Evidence-first 2026 review of creatine for cognition, memory, sleep deprivation, depression, brain energy metabolism, and kidney safety, including corrected meta-analytic and citation caveats.
Read articleGinkgo Biloba 240 mg: What the Evidence Actually Supports
Evidence-first 2026 review of Ginkgo biloba 240 mg and EGb 761: dementia symptom trials, negative prevention data, MCI, healthy cognition, product directness, bleeding/warfarin evidence, and why 240 mg is not a universal dose.
Read articleGrüns Gummies Review: What the Scientific Evidence Actually Shows (2026)
Evidence-first review of Grüns Superfoods Gummies: the 120-person clinical study, current Supplement Facts, proprietary blend limits, fiber, third-party testing, safety, and what the finished product has not been shown to do.
Read articleKava for Anxiety: Does It Work for Social Anxiety? Evidence & Liver Safety
Evidence-first 2026 review of kava for anxiety: the negative 171-person GAD trial, older mixed RCTs, social-anxiety and kava-drink evidence gaps, liver injury, interactions, and why water extracts are not risk-free.
Read articleLion's Mane for ADHD vs Prescription Stimulants: What the Evidence Shows (2026)
Evidence-first comparison of Lion's Mane and prescription ADHD stimulants. No ADHD-specific Lion's Mane trial was identified; current stimulant evidence, newer healthy-adult Lion's Mane trials, mechanisms, safety, and evidence-transfer limits are reviewed.
Read articleMagnesium Glycinate Nightly: Sleep Evidence & Long-Term Safety — 2026 Review
Evidence-first review of magnesium glycinate and bisglycinate for sleep, including the 2025 randomized trial, the small effect size, what is known about nightly safety, what is not known beyond four weeks, kidney risk, supplemental upper limits, and medication interactions.
Read articleMitragynine Pseudoindoxyl: Tablets, Withdrawal, Product Market & Federal Status (2026)
Evidence-first August 2026 review of mitragynine pseudoindoxyl covering mu-opioid pharmacology, human withdrawal reports, commercial tablets and product marketing, DEA temporary-scheduling notice, labeling uncertainty, and the distinction from botanical kratom leaf.
Read articleMushroom Coffee Benefits: What the Science Actually Says
An evidence-based review of mushroom coffee benefits, caffeine, lion's mane, cordyceps, reishi and chaga — including human evidence, safety, dose limitations and how to read a product label.
Read articleCan You Combine Natural Sleep Aids With Sleep Medications? Safety Evidence (2026)
Evidence-first safety guide to combining melatonin, valerian, ashwagandha, magnesium and other supplements with prescription or OTC sleep medicines. Covers additive sedation, Z-drug warnings, next-morning impairment, interaction uncertainty, and why timing gaps are not a universal safety workaround.
Read articleSaffron vs Fluoxetine for Depression: What the Trials Actually Show
Evidence-first 2026 review of saffron vs fluoxetine and other antidepressants for depression: 34-RCT GRADE meta-analysis, SSRI comparisons, placebo trials, safety, pregnancy, and why no-difference does not prove equivalence.
Read articleValerian Root for Sleep: Does It Work? Evidence Review (2026)
Does valerian root actually help sleep or insomnia? A 15-source evidence review covering the 2024 umbrella review, a newer positive RCT, older meta-analyses, dose uncertainty, safety, interactions and how valerian compares with real insomnia treatment.
Read articleCorynoxine B: Opioid Activity, Addiction Relevance, and Safety Evidence
A deeply researched evidence review of corynoxine B, including human mu-opioid receptor activity, conflicting assay results, G-protein bias, addiction and dependence questions, brain exposure, autophagy research, and major safety gaps.
Read articleMitragynine: Pharmacology, Safety, and Clinical Evidence
Evidence-based review of mitragynine covering pharmacokinetics, metabolism to 7-hydroxymitragynine, mu-opioid mechanisms, safety profile, dependence liability, and the critical distinction between traditional leaf and concentrated products.
Read articleBacopa Monnieri: Memory, Cognition & Evidence — 2026 Review
Evidence-first 2026 review of Bacopa monnieri (Brahmi), including older memory trials, a 2026 network meta-analysis, a 2025 null-primary-outcome RCT, cognitive-domain limits, product directness, safety, and dosing uncertainty.
Read articleLion's Mane Mushroom: Cognition, Mood, Dose & Evidence — 2026 Review
Evidence-first 2026 review of Lion's Mane (Hericium erinaceus): small human cognition trials, newer null and mixed findings in healthy adults, product-form directness, preclinical NGF mechanisms, dosing uncertainty, and safety limits.
Read articleTongkat Ali vs Ashwagandha: Testosterone Evidence Compared
Compare human evidence for tongkat ali vs ashwagandha on testosterone and stress, including who was studied, extract-specific results, safety limits, and what we do not know about stacking.
Read articleMagnesium + L-Theanine for Sleep: Evidence and Combination Limits
What human studies actually show about magnesium and L-theanine for sleep, what has not been tested about the two-ingredient combination, and the safety context that matters.
Read articlePeptides Research Guide: Collagen, Approved Drugs & Experimental Peptides
Evidence-first guide to a confusing peptide landscape: food-derived collagen peptides, FDA-approved peptide drugs, compounded drugs, and experimental peptides such as BPC-157, TB-500, ipamorelin, and CJC-1295.
Read articleRhodiola Rosea: What the Human Evidence Supports in 2026
Evidence-first review of Rhodiola rosea for fatigue, stress-related performance, and endurance, including mixed trial results, extract directness, safety limits, and what studies do not establish.
Read articleState of Supplement Evidence 2026: What the Current Library Can and Can't Show
A transparent guide to interpreting the evidence labels in The Hippie Scientist library, including what the live Evidence Report measures, what it does not measure, and why the distribution changes as profiles are reviewed.
Read articleL-Theanine: Benefits, Dose, Sleep & Focus — 2026 Evidence Review
What randomized trials and recent meta-analyses say about L-theanine for attention, stress, anxiety, sleep, caffeine pairing, dosage, and safety.
Read articleFC-004: When Blotter Wasn't LSD — The 25B-NBOMe Seizure Case
A forensic reconstruction of a severe 25B-NBOMe poisoning in a teenager who swallowed blotter sold as LSD, developed repeated seizures, respiratory failure, rhabdomyolysis, and acute kidney injury, and survived intensive care.
Read articleFC-003: Oklahoma's Bromo-DragonFLY Poisoning and the False-Identity Failure Chain
A forensic reconstruction of the 2011 Konawa, Oklahoma poisoning in which material represented as 2C-E was reported to be Bromo-DragonFLY, leaving eight people critically ill and two dead.
Read articleFC-001: Injected Mushroom Tea and the ICU Case Behind 'Mushrooms in His Blood'
A forensic reconstruction of a 2021 case report in which nonsterile mushroom tea was injected intravenously, followed by bacterial and fungal bloodstream infection, septic shock, respiratory failure, and multiorgan injury.
Read articleFC-002: The Illicit Opioid Batch That Produced Permanent Parkinsonism
A forensic reconstruction of the MPTP poisoning cluster in which a contaminant from illicit meperidine-analog synthesis caused abrupt, severe, and lasting parkinsonism—and transformed Parkinson's research.
Read articleWhen the Label Lies: Eight Hallucinogen Disasters and the Failure Chains Behind Them
Eight documented toxicology case studies involving Bromo-DragonFLY, NBOMe and NBOH compounds, DOM/STP, LSD, ibogaine, and Datura—examining misidentification, delayed onset, cardiac toxicity, delirium, and failures of underground drug information.
Read articleBorderline Personality Disorder, Supplements, and Vitamins: What the Evidence Shows
Evidence-based review of supplements and vitamins studied in borderline personality disorder (BPD) — omega-3 fatty acids, vitamin D, magnesium, and others — covering randomized trial data, meta-analyses, symptom domains, safety, and why supplements are at most an adjunct to psychotherapy.
Read articleAdaptogenic Compounds Guide: HPA Axis, Cortisol & Clinical Evidence
Evidence-based overview of adaptogenic compounds — ashwagandha, rhodiola, ginseng, tulsi — covering HPA axis regulation, cortisol, stress resilience, and key clinical trial findings.
Read articleDihydro-7-hydroxy Mitragynine (MGM-15): Chemistry, Pharmacology, and Emerging Risks
MGM-15 is a potent semi-synthetic opioid derived from 7-hydroxymitragynine. Learn what is currently known about its chemistry, pharmacology, risks, and lack of human safety data.
Read articleElderberry for Colds & Flu: Benefits, Dosage & Clinical Evidence
Evidence-based guide to elderberry for cold and flu. Covers dosage, mechanisms, clinical trial results, safety, and practical guidance on what the research actually shows.
Read articleThe Entourage Effect in Herbal Supplements: Evidence Review
A skeptical, evidence-based guide to the entourage effect in natural compounds, including full-spectrum extracts, phytochemical synergy, clinical evidence, stacking logic, and safety limits.
Read articleFunctional Mushrooms Guide: Reishi, Cordyceps, Chaga & Turkey Tail
Evidence-based comparison of reishi, cordyceps, chaga, and turkey tail mushrooms. Covers benefits, mechanisms, dosage, quality markers, and how to choose supplements.
Read articleNatural Compounds: Biosynthetic Gene Clusters and Drug Discovery
An evidence-based deep dive into biosynthetic gene clusters (BGCs) and cheminformatic space mapping, showing how genome mining and chemical clustering are transforming natural product supplement discovery.
Read articlePassionflower for Anxiety & Sleep: Benefits, Dosage & Evidence
Evidence-based guide to passionflower (Passiflora incarnata) for anxiety and sleep. Covers GABA mechanisms, clinical trial results, dosing, and how it compares to kava, valerian, and ashwagandha.
Read articleHow to Choose a Quality Supplement: Testing, Labels, and Red Flags
A practical guide to evaluating supplement quality — third-party certifications (USP, NSF, ConsumerLab), label reading, red flags, and how to avoid adulterated or mislabeled products.
Read article2C-B Effects: Human Evidence, Risks, Pharmacology & What We Still Don't Know
Evidence-first review of 2C-B effects from controlled human studies, observational research, toxicology reports, pharmacology, legal status, and harm-reduction limits—without dosing instructions.
Read articleCacao and Theobromine: A Gentle Stimulant Profile
Exploring how ceremonial cacao delivers uplift through theobromine, polyphenols, and mindful preparation.
Read articleNightly Herb Blends: How to Build One Without Guessing
A safer evidence-first framework for evaluating bedtime herbal blends without assuming that more ingredients, stronger doses, or traditional use automatically produce better sleep.
Read articleLion's Mane and BDNF: What the Evidence Shows
Reviewing how Hericium erinaceus extracts may influence brain-derived neurotrophic factor and cognitive resilience.
Read articleYerba Mate vs Green Tea: Caffeine, Focus, Metabolic Evidence & Safety
Evidence-first comparison of yerba mate and green tea: caffeine variability, L-theanine/cognition research, metabolic evidence, very-hot beverage risk, green-tea-extract liver safety, and what has never been tested head-to-head.
Read articleKanna (Sceletium) for Mood and Focus
How traditional Sceletium extracts may lift mood and sharpen attention without overstimulation.
Read articleReishi for Sleep and Immunity: What Human Studies Actually Show
Reishi has interesting preclinical biology and some human immune research, but direct human sleep evidence remains sparse. Here is what the evidence can and cannot support.
Read articleEditorial reading context
How to read Articles
Research notes, evidence reviews, regulatory updates, and editorial deep dives on herbs, compounds, and emerging psychoactive substances. This guide is intended to help readers make sense of evidence, safety, and practical fit without turning supplement research into a one-size-fits-all checklist. Use it alongside the linked herb and compound profiles for deeper mechanism and safety details.
For Articles, focus on whether the evidence matches the exact outcome you care about, whether the dose discussed is realistic, and whether the safety profile fits your medical context. Strong marketing language should carry less weight than human evidence and transparent product quality.
When a page discusses dependence-forming substances, restricted compounds, or high-risk contexts, treat it as harm-reduction education only. It is not a buying guide, dosing instruction, or substitute for professional care.